Clinical Trial Update: Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of naltrexone and fluoxetine for individuals with alcohol use disorder and comorbid depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Major Depressive Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)
• Naltrexone (Naltrexone)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcoholism, Alcohol Dependence | Phase 4 | Status: COMPLETED